BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

607 related articles for article (PubMed ID: 25146396)

  • 1. The VCP/p97 system at a glance: connecting cellular function to disease pathogenesis.
    Meyer H; Weihl CC
    J Cell Sci; 2014 Sep; 127(Pt 18):3877-83. PubMed ID: 25146396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenic Mutations in the Valosin-containing Protein/p97(VCP) N-domain Inhibit the SUMOylation of VCP and Lead to Impaired Stress Response.
    Wang T; Xu W; Qin M; Yang Y; Bao P; Shen F; Zhang Z; Xu J
    J Biol Chem; 2016 Jul; 291(27):14373-14384. PubMed ID: 27226613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valosin-Containing Protein (VCP)/p97: A Prognostic Biomarker and Therapeutic Target in Cancer.
    Costantini S; Capone F; Polo A; Bagnara P; Budillon A
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valosin-containing Protein (VCP)/p97 Segregase Mediates Proteolytic Processing of Cockayne Syndrome Group B (CSB) in Damaged Chromatin.
    He J; Zhu Q; Wani G; Sharma N; Wani AA
    J Biol Chem; 2016 Apr; 291(14):7396-408. PubMed ID: 26826127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging functions of the VCP/p97 AAA-ATPase in the ubiquitin system.
    Meyer H; Bug M; Bremer S
    Nat Cell Biol; 2012 Feb; 14(2):117-23. PubMed ID: 22298039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transgenic mice expressing mutant forms VCP/p97 recapitulate the full spectrum of IBMPFD including degeneration in muscle, brain and bone.
    Custer SK; Neumann M; Lu H; Wright AC; Taylor JP
    Hum Mol Genet; 2010 May; 19(9):1741-55. PubMed ID: 20147319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunoexpression of valosin-containing protein and small VCP-interacting protein in rat ovaries.
    Kartal B; Alimoğulları E; Çaylı S
    Anat Histol Embryol; 2023 Jul; 52(4):546-551. PubMed ID: 36843060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COP9 signalosome interacts ATP-dependently with p97/valosin-containing protein (VCP) and controls the ubiquitination status of proteins bound to p97/VCP.
    Cayli S; Klug J; Chapiro J; Fröhlich S; Krasteva G; Orel L; Meinhardt A
    J Biol Chem; 2009 Dec; 284(50):34944-53. PubMed ID: 19826004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VCP/p97 is essential for maturation of ubiquitin-containing autophagosomes and this function is impaired by mutations that cause IBMPFD.
    Tresse E; Salomons FA; Vesa J; Bott LC; Kimonis V; Yao TP; Dantuma NP; Taylor JP
    Autophagy; 2010 Feb; 6(2):217-27. PubMed ID: 20104022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Create and preserve: proteostasis in development and aging is governed by Cdc48/p97/VCP.
    Franz A; Ackermann L; Hoppe T
    Biochim Biophys Acta; 2014 Jan; 1843(1):205-15. PubMed ID: 23583830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UV-induced proteolysis of RNA polymerase II is mediated by VCP/p97 segregase and timely orchestration by Cockayne syndrome B protein.
    He J; Zhu Q; Wani G; Wani AA
    Oncotarget; 2017 Feb; 8(7):11004-11019. PubMed ID: 28036256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between salt-inducible kinase 2 (SIK2) and p97/valosin-containing protein (VCP) regulates endoplasmic reticulum (ER)-associated protein degradation in mammalian cells.
    Yang FC; Lin YH; Chen WH; Huang JY; Chang HY; Su SH; Wang HT; Chiang CY; Hsu PH; Tsai MD; Tan BC; Lee SC
    J Biol Chem; 2013 Nov; 288(47):33861-33872. PubMed ID: 24129571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inclusion body myopathy-associated mutations in p97/VCP impair endoplasmic reticulum-associated degradation.
    Weihl CC; Dalal S; Pestronk A; Hanson PI
    Hum Mol Genet; 2006 Jan; 15(2):189-99. PubMed ID: 16321991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expanding into new markets--VCP/p97 in endocytosis and autophagy.
    Bug M; Meyer H
    J Struct Biol; 2012 Aug; 179(2):78-82. PubMed ID: 22450227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in p97/VCP/Cdc48 cellular functions.
    Yamanaka K; Sasagawa Y; Ogura T
    Biochim Biophys Acta; 2012 Jan; 1823(1):130-7. PubMed ID: 21781992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The differentiation/retrodifferentiation program of human U937 leukemia cells is accompanied by changes of VCP/p97.
    Bertram C; von Neuhoff N; Skawran B; Steinemann D; Schlegelberger B; Hass R
    BMC Cell Biol; 2008 Feb; 9():12. PubMed ID: 18279508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inclusion body myopathy, Paget's disease of the bone and fronto-temporal dementia: a disorder of autophagy.
    Ju JS; Weihl CC
    Hum Mol Genet; 2010 Apr; 19(R1):R38-45. PubMed ID: 20410287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and mechanistic insights into the arginine/lysine-rich peptide motifs that interact with P97/VCP.
    Liu S; Fu QS; Zhao J; Hu HY
    Biochim Biophys Acta; 2013 Dec; 1834(12):2672-8. PubMed ID: 24100225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From neurodevelopment to neurodegeneration: the interaction of neurofibromin and valosin-containing protein/p97 in regulation of dendritic spine formation.
    Hsueh YP
    J Biomed Sci; 2012 Mar; 19(1):33. PubMed ID: 22449146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UBX domain proteins: major regulators of the AAA ATPase Cdc48/p97.
    Schuberth C; Buchberger A
    Cell Mol Life Sci; 2008 Aug; 65(15):2360-71. PubMed ID: 18438607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.